期刊文献+

我院质子泵抑制剂应用情况分析 被引量:3

Clinical Application of Proton Pump Inhibitors
下载PDF
导出
摘要 目的:调查目前临床上质子泵抑制剂(PPI)的给药方式,探讨常用给药方案的合理性。方法:统计2007年4月~9月半年内我院住院患者中服用PPI的情况。结果:临床上最常用的给药方式为1日2次,占给药方案的54.52%,其中93.3%(埃索美拉唑和奥美拉唑,20mg,bid)是应用于非幽门螺杆菌根除的其他适应证治疗。结论:本研究证明目前临床PPI给药方案与说明书中规定用法用量存在较大差异。 OBJECTIVE: To investigate the direction for use and dosage of PPI and to discuss the rationality of their common dosage regimes. METHODS: The use of PPI in the inpatients in our hospital from Apr. l to Set. 30 in 2007 were analyzed statistically. RESULTS: 54.52% of the PPI were administered bid. Of which, 93.3% (esomeprazole and omeprazole 20mg bid) were used for indications other than Helicobacter pylori eradication. CONCLUSION: The dosage regimens of PPI are greatly different from that specified in drug package inserts.
出处 《中国医院用药评价与分析》 2008年第3期194-197,共4页 Evaluation and Analysis of Drug-use in Hospitals of China
关键词 质子泵抑制剂 用药分析 Proton pump inhibitors Analysis of drug use
  • 相关文献

参考文献7

  • 1Katz P,Miner P,Chen Y,et al.Effects of 5 marketed proton pump inhibitors on acid suppression relative to a range of pH thresholds[J].Am J Gastroenterol,2004,99(12):2 385.
  • 2Fennerty MB,Johanson J,Hwang C,et al.Esomeprazole 40 mg versus lansoprazole 30 mg in healing and symptomatic relief in patients with moderate to severe erosive esophagitis(Los Angeles Grades C or D)[J].Am J Gastroenterol,2004,99:S4.
  • 3Pezanoski JP,Gunaratnam NT,Gamarra R,et al.Correct and incorrect dosing of proton pump inhibitom and its impact on GELID symptoms[J].Am J Gastroenterol,2004,99:S11.
  • 4Shimatani T,Inane M,Kuroiwa T,et al.Acid-suppressive effects of rabeprazole,omeprazole,and lanseprazole at reduced and standard doses a crossover comparative study in homozygous extensive metabolizers of cytochrome P450 2C19[J].Clin Pharmcol Ther,2006,79(1):144.
  • 5Shirnatani T,Kuroiwa T,Moriwaki M,et al.Acid-suppressive effects of various regimens of omeprazole in Helicobacter pylori-negative CYP2C19 homozygous extensive metabolizers:which regimen has the strongest effect?[J].Dig Dis Sci,2007,52(10):2826.
  • 6Groeneveld TW,OroszlanM,Owens RT,et al.Interactions of the oxtracellularmatrix proteoglycans decofin and biglycan with Clq and coUectins[J].J lmmunol,2005,175(7):4715.
  • 7Park W,Hicks D,Ableson T,et al.Is twice a day PPI better than once a day PPI for the treatment of GERD related ENT symptoms?[J].Am J Gastroenterol,2004,99:S26.

同被引文献40

引证文献3

二级引证文献18

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部